Prelude Therapeutics Inc (PRLD)

04:31 AM

Tick level data insight on Prelude Therapeutics Incorporated volatilityPortfolio Performance Summary & Technical Confirmation Trade Alerts - Newser

04:31 AM

04:09 AM

Quantitative breakdown of Prelude Therapeutics Incorporated recent moveJuly 2025 Sentiment & Fast Gain Swing Trade Alerts - Newser

04:09 AM

03:51 AM

Chart overlay techniques for tracking Prelude Therapeutics IncorporatedJuly 2025 News Drivers & Accurate Trade Setup Notifications - Newser

03:51 AM

02:28 AM

Price momentum metrics for Prelude Therapeutics Incorporated explainedBull Run & Technical Pattern Recognition Alerts - Newser

02:28 AM

02:14 AM

Does Prelude Therapeutics Incorporated qualify in momentum factor screening2025 Valuation Update & Advanced Technical Analysis Signals - Newser

02:14 AM

12:56 PM

Is it time to cut losses on Prelude Therapeutics IncorporatedJuly 2025 Volume & AI Driven Price Forecasts - Newser

12:56 PM

12:08 PM

Prelude Therapeutics Incorporated stock trendline breakdown2025 Winners & Losers & Comprehensive Market Scan Insights - Newser

12:08 PM

Aug 15, 2025

Will Prelude Therapeutics Incorporated bounce back from current supportQuarterly Investment Review & Safe Entry Momentum Tips - Newser

Aug 15, 2025

Aug 15, 2025

Will Prelude Therapeutics Incorporated stock go up soon2025 Sector Review & High Yield Stock Recommendations - Newser

Aug 15, 2025

Aug 15, 2025

Prelude Therapeutics Incorporated recovery potential after sell offQuarterly Profit Report & Daily Profit Focused Screening - Newser

Aug 15, 2025

Aug 15, 2025

Neurizon cites ‘strain’ at FDA as reason for delay on IND hold; Fifty Years’ $126M fund - Endpoints News

Aug 15, 2025

Aug 15, 2025

What makes Prelude Therapeutics Incorporated stock price move sharplyOptions Play & Long-Term Investment Growth Plans - Newser

Aug 15, 2025

Aug 15, 2025

Best data tools to analyze Prelude Therapeutics Incorporated stockEarnings Performance Report & Risk Managed Investment Entry Signals - Newser

Aug 15, 2025

Aug 15, 2025

Prelude Therapeutics Reports Q2 2025 Financial Results - TipRanks

Aug 15, 2025

Aug 14, 2025

Prelude Cuts Q2 Losses and Costs 13% - The Motley Fool

Aug 14, 2025

Aug 14, 2025

Prelude (PRLD) Announces Q2 2025 Results; Presentation Attached | PRLD SEC FilingForm 8-K - Stock Titan

Aug 14, 2025

Aug 14, 2025

Prelude Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - Yahoo Finance

Aug 14, 2025

Aug 13, 2025

Why Prelude Therapeutics Incorporated stock attracts strong analyst attention2025 Historical Comparison & Risk Controlled Stock Pick Alerts - Newser

Aug 13, 2025

Aug 13, 2025

How to build a dashboard for Prelude Therapeutics Incorporated stockPortfolio Update Summary & Stepwise Swing Trade Plans - Newser

Aug 13, 2025

Aug 13, 2025

What recovery options are there for Prelude Therapeutics Incorporated [July 2025 Sentiment]High Yield Equity Trading Tips - Newser

Aug 13, 2025

Aug 12, 2025

Is Prelude Therapeutics Incorporated reversing from oversold territoryFree Value Investing Picks With Stability - Newser

Aug 12, 2025

Aug 11, 2025

Using data filters to optimize entry into Prelude Therapeutics IncorporatedAsset Safety Selection Using Quantitative Analysis - Newser

Aug 11, 2025

Aug 11, 2025

Published on: 2025-08-11 08:04:14 - Newser

Aug 11, 2025

Aug 11, 2025

Can Prelude Therapeutics (NASDAQ:PRLD) Afford To Invest In Growth? - Yahoo Finance

Aug 11, 2025

Aug 10, 2025

Prelude Therapeutics Incorporated’s volatility index tracking explainedMulti-Year Signal Summary and Entry Timing - Newser

Aug 10, 2025

Aug 10, 2025

Can machine learning forecast Prelude Therapeutics Incorporated recoveryLong Term Stock Planner with Safety Checks - Newser

Aug 10, 2025

Aug 09, 2025

Prelude Therapeutics (PRLD) to Release Quarterly Earnings on Monday - Defense World

Aug 09, 2025

Aug 08, 2025

Published on: 2025-08-08 17:57:29 - Newser

Aug 08, 2025

Aug 08, 2025

Prelude Therapeutics Inc expected to post a loss of 44 cents a shareEarnings Preview - TradingView

Aug 08, 2025